Abrar Abdullah

Evaluation of in vitro activity of ceftolozane/tazobactam and comparators against recent clinical bacterial isolates, and genomics of Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli isolates that demonstrated resistance to ceftolozane/tazobactam: data from Kuwait and Oman

A. Mustafa, E. Mokaddas, W. Alfouzan, 2022, JAC-antimicrobial resistance.